On January 15, 2026, President Trump called on Congress to enact The Great Healthcare Plan, which would lower drug prices by codifying the savings from his Most-Favored-Nation pricing initiative, ...

Merck on Tuesday revealed a lower-than-expected outlook for 2026 as the drugmaker aims to remake its business before its ...

A new kind of pill sharply reduced cholesterol in people at high risk of heart attacks despite taking statins.

On Tuesday, Medtronic announced intent to acquire CathWorks, an Israel-based medical technology company, for $585 million. CathWorks has its U.S. headquarters in California and specializes in ...

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this ...

Moderna licensed out a rare disease drug for what an analyst called a “modest” sum. Elsewhere, Roche executives suggested better forthcoming obesity results and Summit’s PD-1/VEGF blocker got an FDA ...

Halozyme is paying as much as $400 million for a drug delivery specialist that could boost its growth prospects, one analyst ...

The Supraventricular Tachycardia market benefits from aging populations, technological advances like catheter ablation, rising cardiovascular awareness, and wearable diagnostics. Growth is supported ...

With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. is bringing together several global vaccine makers to develop an updated Ebola vaccine to ...

About every 34 seconds, someone, somewhere in the United States dies from heart disease — which remains the leading cause of death for both men and women, according to the American Heart Association.

BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with US based ...

Merck MRK1.35%increase; green up pointing triangle is in talks to acquire Revolution Medicines RVMD 0.89%increase; green up pointing triangle in a deal that could value it at around $30 billion, ...